Skip to main content

NL
FR
EN

Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Search

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Veterinary use
Medicines
Current Page:Medicines

Medicines

Scientific-Technical Advice
Research & Development
- Clinical trials
Marketing Authorisation procedures
Pharmacovigilance
Production
Distribution & delivery
Authorisation - Certificates
Declarations
- Medicines for export
- Manufacturing activity as a sub-contractor
Proper use

Last updated on 16/12/2020

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

13/05/2022

PRAC May 2022 – Discussion regarding a direct healthcare professional communication (DHPC) containing important information for Defitelio

13/05/2022

Call for tender by the European Commission: reservation of manufacturing capacities and priority right to manufacture vaccines

29/04/2022

Symposium on vaccines on 10 and 12 May 2022: the importance of lifelong immunisation, lessons from the COVID-19 pandemic, and future prospects

25/04/2022

Impact of war in Ukraine on clinical trials

© 2016 - FAMHP

MNP-202141
MNP-202139
Zeposia (Celgene)
Privacy
Disclaimer

instructions how to enable JavaScript in your web browser